Search - tctmd.com

Displaying 101 - 113 of 113

Sort: Relevancy | Date

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

L.A. McKeown

February 22, 2015

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

L.A. McKeown

September 20, 2013

News Daily News

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

L.A. McKeown

September 20, 2013

News Daily News

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

L.A. McKeown

August 15, 2012

News Daily News

La PCI y la Cirugía Confirman Mortalidad a Largo Plazo en Pacientes Diabéticos y No Diabéticos

L.A. McKeown

August 15, 2012

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Daily News

BARI 2D: Prompt Revascularization Improves Angina Symptoms in Diabetics

L.A. McKeown

April 01, 2011

Advertisement

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

La PCI y la Cirugía Confirman Mortalidad a Largo Plazo en Pacientes Diabéticos y No Diabéticos

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

BARI 2D: Prompt Revascularization Improves Angina Symptoms in Diabetics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content